Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women
Sponsor: Pharmanutra S.p.a.
Summary
This study aims to compare two oral iron treatments, Sucrosomial® Iron and Ferric Maltol, in women with mild to moderate iron deficiency anemia. Many patients experience gastrointestinal side effects or poor tolerability with traditional iron supplements, which may limit adherence. Participants will be randomly assigned to receive either Sucrosomial® Iron or Ferric Maltol for 12 weeks. The primary objective is to determine whether Sucrosomial® Iron is as effective as Ferric Maltol in normalizing hemoglobin levels.
Official title: A Prospective, Open-Label, Randomized, Interventional Study to Evaluate the Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
146
Start Date
2025-12-11
Completion Date
2026-10
Last Updated
2026-03-23
Healthy Volunteers
No
Conditions
Interventions
Sucrosomial® Iron (Sideral® Forte)
Sucrosomial® Iron (Sideral® Forte), 30 mg elemental iron per capsule
Ferric Maltol (Feraccru®)
Ferric Maltol (Feraccru®), 30 mg elemental iron per capsule
Locations (7)
Hospital Quironsalud Barcelona
Barcelona, Spain
Hospital Universitari Dexeus Grupo Quironsalud
Barcelona, Spain
Hospital Universitari Sagrat Cor
Barcelona, Spain
Hospital Quironsalud Malaga
Málaga, Spain
Hospital Quironsalud Malága
Málaga, Spain
Hospital Universitari General De Catalunya
Sant Cugat del Vallès, Spain
Hospital Quironsalud Zaragoza
Zaragoza, Spain